Certuity’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.53K | Hold |
14,712
| – | – | ﹤0.01% | 424 |
|
|
2025
Q1 | $8.33K | Hold |
14,712
| – | – | ﹤0.01% | 403 |
|
|
2024
Q4 | $31K | Hold |
14,712
| – | – | ﹤0.01% | 375 |
|
|
2024
Q3 | $39.6K | Buy |
14,712
+12
| +0.1% | +$32 | ﹤0.01% | 349 |
|
|
2024
Q2 | $41.9K | Buy |
14,700
+325
| +2% | +$926 | ﹤0.01% | 348 |
|
|
2024
Q1 | $61K | Hold |
14,375
| – | – | 0.01% | 316 |
|
|
2023
Q4 | $76.9K | Hold |
14,375
| – | – | 0.01% | 335 |
|
|
2023
Q3 | $61.8K | Buy |
14,375
+35
| +0.2% | +$151 | 0.01% | 255 |
|
|
2023
Q2 | $78.7K | Hold |
14,340
| – | – | 0.01% | 257 |
|
|
2023
Q1 | $60.2K | Hold |
14,340
| – | – | 0.01% | 216 |
|
|
2022
Q4 | $39.7K | Hold |
14,340
| – | – | 0.01% | 208 |
|
|
2022
Q3 | $37K | Sell |
14,340
-24,960
| -64% | -$64.4K | 0.01% | 190 |
|
|
2022
Q2 | $141K | Buy |
39,300
+1,000
| +3% | +$3.59K | 0.04% | 208 |
|
|
2022
Q1 | $238K | Hold |
38,300
| – | – | 0.05% | 254 |
|
|
2021
Q4 | $270K | Hold |
38,300
| – | – | 0.06% | 235 |
|
|
2021
Q3 | $267K | Hold |
38,300
| – | – | 0.05% | 300 |
|
|
2021
Q2 | $319K | Buy |
+38,300
| New | +$319K | 0.07% | 219 |
|